<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<?properties manuscript?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">8809320</journal-id>
<journal-id journal-id-type="pubmed-jr-id">1600</journal-id>
<journal-id journal-id-type="nlm-ta">Neuron</journal-id>
<journal-id journal-id-type="iso-abbrev">Neuron</journal-id>
<journal-title-group>
<journal-title>Neuron</journal-title>
</journal-title-group>
<issn pub-type="ppub">0896-6273</issn>
<issn pub-type="epub">1097-4199</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27021170</article-id>
<article-id pub-id-type="pmc">4824651</article-id>
<article-id pub-id-type="doi">10.1016/j.neuron.2016.02.040</article-id>
<article-id pub-id-type="manuscript">NIHMS766003</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>GABAergic neuron-specific loss of <italic>Ube3a</italic> causes Angelman syndrome-like EEG abnormalities and enhances seizure susceptibility</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Judson</surname>
<given-names>Matthew C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wallace</surname>
<given-names>Michael L.</given-names>
</name>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="author-notes" rid="FN1">‡</xref>
<xref ref-type="author-notes" rid="FN2">#</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sidorov</surname>
<given-names>Michael S.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Burette</surname>
<given-names>Alain C.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gu</surname>
<given-names>Bin</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>van Woerden</surname>
<given-names>Geeske M.</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>King</surname>
<given-names>Ian F.</given-names>
</name>
<xref ref-type="aff" rid="A6">6</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Han</surname>
<given-names>Ji Eun</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zylka</surname>
<given-names>Mark J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A7">7</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Elgersma</surname>
<given-names>Ype</given-names>
</name>
<xref ref-type="aff" rid="A4">4</xref>
<xref ref-type="aff" rid="A5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Weinberg</surname>
<given-names>Richard J.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Philpot</surname>
<given-names>Benjamin D.</given-names>
</name>
<xref ref-type="aff" rid="A1">1</xref>
<xref ref-type="aff" rid="A2">2</xref>
<xref ref-type="aff" rid="A3">3</xref>
<xref ref-type="aff" rid="A7">7</xref>
<xref ref-type="corresp" rid="cor1">*</xref>
</contrib>
</contrib-group>
<aff id="A1"><label>1</label>Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, 27599-7545</aff>
<aff id="A2"><label>2</label>Curriculum in Neurobiology, University of North Carolina, Chapel Hill 27599-7250</aff>
<aff id="A3"><label>3</label>Carolina Institute for Developmental Disabilities, University of North Carolina, Chapel Hill, 27599-7255</aff>
<aff id="A4"><label>4</label>Department of Neuroscience, Erasmus Medical Center, Wytemaweg 80, NL-3015 CN Rotterdam, the Netherlands</aff>
<aff id="A5"><label>5</label><italic>ENCORE</italic> Center for Neurodevelopmental Disorders, Erasmus Medical Center, Rotterdam, Wytemaweg 80, 3015 CN, the Netherlands</aff>
<aff id="A6"><label>6</label>Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, 27599-7525</aff>
<aff id="A7"><label>7</label>Neuroscience Center, University of North Carolina, Chapel Hill, 27599-7250</aff>
<author-notes>
<corresp id="cor1"><label>*</label>Correspondence: <email>bphilpot@med.unc.edu</email></corresp>
<fn fn-type="present-address" id="FN1">
<label>‡</label>
<p id="P1">Present address: Department of Neurobiology, Harvard Medical School, Boston, 02115</p>
</fn>
<fn fn-type="equal" id="FN2">
<label>#</label>
<p id="P2">These authors contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>9</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>24</day>
<month>3</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="ppub">
<day>6</day>
<month>4</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>06</day>
<month>4</month>
<year>2017</year>
</pub-date>
<volume>90</volume>
<issue>1</issue>
<fpage>56</fpage>
<lpage>69</lpage>
<!--elocation-id from pubmed: 10.1016/j.neuron.2016.02.040-->
<abstract>
<title>SUMMARY</title>
<p id="P3">Loss of maternal <italic>UBE3A</italic> causes Angelman syndrome (AS), a neurodevelopmental disorder associated with severe epilepsy. We previously implicated GABAergic deficits onto layer (L) 2/3 pyramidal neurons in the pathogenesis of neocortical hyperexcitability, and perhaps epilepsy, in AS model mice. Here we investigate consequences of selective <italic>Ube3a</italic> loss from either GABAergic or glutamatergic neurons, focusing on the development of hyperexcitability within L2/3 neocortex and in broader circuit and behavioral contexts. We find that GABAergic <italic>Ube3a</italic> loss causes AS-like increases in neocortical EEG delta power, enhances seizure susceptibility, and leads to presynaptic accumulation of clathrin-coated vesicles (CCVs) – all without decreasing GABAergic inhibition onto L2/3 pyramidal neurons. Conversely, glutamatergic <italic>Ube3a</italic> loss fails to yield EEG abnormalities, seizures, or associated CCV phenotypes, despite impairing tonic inhibition onto L2/3 pyramidal neurons. These results substantiate GABAergic <italic>Ube3a</italic> loss as the principal cause of circuit hyperexcitability in AS mice, lending insight into ictogenic mechanisms in AS.</p>
</abstract>
</article-meta>
</front>
</article>
</pmc-articleset>